Skip to main content

Table 2 Odds ratios for surgical treatmenta for people with non-metastatic non-small cell lung cancer in NSW 2001–2007b

From: Lung cancer treatment and mortality for Aboriginal people in New South Wales, Australia: results from a population-based record linkage study and medical record audit

 

Odds ratioc (95 % CI)

p-value

Aboriginal

0.70 (0.46–1.05)

0.084

Sex

 

0.042

 Male

1.00

 

 Female

1.12 (1.00–1.24)

 

Age at diagnosis (years)

 

<0.001

 18–49

1.00

 

 50–59

0.89 (0.68–1.15)

 

 60–69

0.90 (0.70–1.14)

 

 70–79

0.58 (0.46–0.74)

 

 80+

0.20 (0.15–0.27)

 

Spread of disease

 

<0.001

 Localised

1.00

 

 Regional

0.81 (0.73–0.90)

 

Year of diagnosis

1.04 (1.02–1.07)

0.001

Place of residence at diagnosis

 

<0.001

 Major cities

1.00

 

 Inner regional

0.69 (0.60–0.80)

 

 Rurald

0.66 (0.51–0.83)

 

Comorbiditiese

  

 Chronic pulmonary disease

1.04 (0.93–1.16)

0.526

 Diabetes

1.08 (0.93–1.25)

0.300

 Cardiovascular disease

0.71 (0.62–0.82)

<0.001

 Renal disease

0.74 (0.56–0.97)

0.029

 Other comorbidities

0.60 (0.49–0.72)

<0.001

Socioeconomic disadvantage quintile

<0.001

 Least disadvantaged

1.00

 

 Second least disadvantaged

0.86 (0.73–1.02)

 

 Third least disadvantaged

0.73 (0.61–0.87)

 

 Second most disadvantaged

0.85 (0.72–1.01)

 

 Most disadvantaged

0.63 (0.51–0.76)

 
  1. CI confidence interval
  2. aSurgical treatment includes pneumonectomy, lobectomy, lung resection or resection of endotracheal tumour
  3. bThere were 120 Aboriginal and 6757 non-Aboriginal people in this analysis
  4. cOdds ratio adjusted for all other variables in the table
  5. dRural includes outer regional, remote and very remote
  6. ePresence vs absence of each comorbidity